Notebook

Martin Marietta Boosts Royalty Split SSC Magnets Attract Criticism PBS Series Looks At Astronomers Chips In The Edifice Of Science NSF Cleans Up Its Antarctic Act Scientists at Oak Ridge National Laboratory and four other DOE facilities operated by Martin Marietta Energy Systems in Tennessee, Ohio, and Kentucky will get higher royalties under a new policy adopted by the government contractor. Martin Marietta will now give inventors of licensed technology 15 percent of gross royalty recei


Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Scientists at Oak Ridge National Laboratory and four other DOE facilities operated by Martin Marietta Energy Systems in Tennessee, Ohio, and Kentucky will get higher royalties under a new policy adopted by the government contractor. Martin Marietta will now give inventors of licensed technology 15 percent of gross royalty receipts, up from 10 percent under the old policy, and those who invented or supported unlicensed technology will get 5 percent of gross royalties from all licenses, up from the current 4 percent. The new policy also removes a $100,000 cap per license. Nearly 100 employees have received a total of $200,000 since the program was begun in 1984, says William Carpenter, the company's vice president for technology transfer, and Martin Marietta has received $1.3 million in royalties on some 49 licenses. "Nobody's reached the limit [on potential royalty earnings]," says Carpenter, "but it's nice to know that we've helped ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide